The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of criticall...
The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial
About this item
Full title
Author / Creator
Doaei, Saeid , Gholami, Somayeh , Rastgoo, Samira , Gholamalizadeh, Maryam , Bourbour, Fatemeh , Bagheri, Seyedeh Elaheh , Samipoor, Forough , Akbari, Mohammad Esmail , Shadnoush, Mahdi , Ghorat, Fereshteh , Mosavi Jarrahi, Seyed Alireza , Ashouri Mirsadeghi, Narjes , Hajipour, Azadeh , Joola, Parvin , Moslem, Alireza and Goodarzi, Mark O
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Omega-3 polyunsaturated fatty acids (n3-PUFAs) may exert beneficial effects on the immune system of patients with viral infections. This paper aimed to examine the effect of n3-PUFA supplementation on inflammatory and biochemical markers in critically ill patients with COVID-19.
A double-blind, randomized clinical trial study was conducted on 128 critically ill patients infected with COVID-19 who were randomly assigned to the intervention (fortified formula with n3-PUFA) (n = 42) and control (n = 86) groups. Data on 1 month survival rate, blood glucose, sodium (Na), potassium (K), blood urea nitrogen (BUN), creatinine (Cr), albumin, hematocrit (HCT), calcium (Ca), phosphorus (P), mean arterial pressure (MAP), O
saturation (O
sat), arterial pH, partial pressure of oxygen (PO
), partial pressure of carbon dioxide (PCO
), bicarbonate (HCO
), base excess (Be), white blood cells (WBCs), Glasgow Coma Scale (GCS), hemoglobin (Hb), platelet (Plt), and the partial thromboplastin time (PTT) were collected at baseline and after 14 days of the intervention.
The intervention group had significantly higher 1-month survival rate and higher levels of arterial pH, HCO
, and Be and lower levels of BUN, Cr, and K compared with the control group after intervention (all P < 0.05). There were no significant differences between blood glucose, Na, HCT, Ca, P, MAP, O2sat, PO
, PCO
, WBCs, GCS, Hb, Plt, PTT, and albumin between two groups.
Omega-3 supplementation improved the levels of several parameters of respiratory and renal function in critically ill patients with COVID-19. Further clinical studies are warranted. Trial registry Name of the registry: This study was registered in the Iranian Registry of Clinical Trials (IRCT); Trial registration number: IRCT20151226025699N3; Date of registration: 2020.5.20; URL of trial registry record: https://en.irct.ir/trial/48213....
Alternative Titles
Full title
The effect of omega-3 fatty acid supplementation on clinical and biochemical parameters of critically ill patients with COVID-19: a randomized clinical trial
Authors, Artists and Contributors
Author / Creator
Gholami, Somayeh
Rastgoo, Samira
Gholamalizadeh, Maryam
Bourbour, Fatemeh
Bagheri, Seyedeh Elaheh
Samipoor, Forough
Akbari, Mohammad Esmail
Shadnoush, Mahdi
Ghorat, Fereshteh
Mosavi Jarrahi, Seyed Alireza
Ashouri Mirsadeghi, Narjes
Hajipour, Azadeh
Joola, Parvin
Moslem, Alireza
Goodarzi, Mark O
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_87377ac6024c4782b3e208c1829f1817
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_87377ac6024c4782b3e208c1829f1817
Other Identifiers
ISSN
1479-5876
E-ISSN
1479-5876
DOI
10.1186/s12967-021-02795-5
